comparemela.com

Page 15 - Josh Nathan Kazis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Baxter and 5 More Medical Device Stocks Primed to Bounce Back

Some investors have worried that new weight-loss drugs could undermine demand for some medical devices.

United statesJosh nathan kazisJoe wolkAnthony petroneBaxter internationalZimmer biomet holdingsCompany tickerAbbott laboratoriesEli lillyNovo nordiskDevice stocks primedBiomet holdingsArticle normalMedical equipment suppliesPort harbor operationsTrusts funds financial vehicles

Pfizer Says Wall Street Was Right On Covid Market

Pfizer ratcheted down its guidance for this year, to a combined $12.5 billion from its Covid-19 vaccine and therapeutic.

Akash tewariDavid dentonChris shibutaniJosh nathan kazisAlbert bourlaGoldman sachsWall streetArticle normalBiotechnology servicesRetail wholesaleHealthcare life sciencesClothing textilesConsumer goodsFinancial performanceOwnership changesAcquisitions mergers shareholdings

Pfizer Stock Drops After Guidance Cut Its Post-Covid Place Is Unsure

The U.S. government will return treatments of the company's Paxlovid drug as coronavirus vaccination rates fall.

United statesBrian swintJosh nathan kazisEvan david seigermanMohit bansalWells fargoCourtesy pfizerEqual weightArticle normalBiotechnology servicesHealthcare life sciencesFinancial performanceShare price movement disruptionsCorporate industrial newsPolitical general newsRespiratory tract diseases

Johnson & Johnson Reports Earnings Tuesday What to Expect

Johnson & Johnson Reports Earnings Tuesday What to Expect
marketwatch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketwatch.com Daily Mail and Mail on Sunday newspapers.

Josh nathan kazisJustin sullivan gettyGetty imagesPharmaceutical index

Pfizer Wins FDA Approval for New Ulcerative Colitis Pill

The treatment is one of a number of new products that the company expects to bring in a combined $20 billion in potential annual revenue by 2030.

Josh nathan kazisAngela hwangBristol myers squibbArena pharmaceuticalsDrug administrationGetty imagesArticle normalHealthcare life sciencesSpecialized drugs medicationsHormone productsRegulation government policyNew products servicesProduct service approvalsCorporate industrial newsProducts servicesAutoimmune diseases

vimarsana © 2020. All Rights Reserved.